Beijing-based Fangda Partners has added two new partners to its Shanghai and Shenzhen offices.
Joining in Shanghai is capital markets partner Aaron Chen, who was most recently a partner at Chinese firm Jiayuan Law Offices. Chen advises on capital markets deals, corporate restructurings as well as private equity investments. He previously advised on the Hong Kong initial public offering of Chinese medical technology platform, WuXi AppTec, which raised $1 billion in 2018. He also acted on the IPO of Top Alliance, also known as Shanghai Junshi Biosciences, which raised $450 million in Hong Kong in the same year.
